Atai Life Sciences Inventory Turnover Ratio 2020-2023 | ATAI

Atai Life Sciences inventory turnover ratio from 2020 to 2023. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
Atai Life Sciences Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.330B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.733B 10.12
Quest Diagnostics (DGX) United States $15.181B 15.69
DaVita (DVA) United States $11.744B 15.98
Chemed (CHE) United States $9.320B 29.33
Encompass Health (EHC) United States $8.258B 22.65
Elanco Animal Health (ELAN) United States $6.651B 15.12
Option Care Health (OPCH) United States $5.317B 20.12
RadNet (RDNT) United States $3.344B 97.66
Amedisys (AMED) United States $2.978B 21.25
LifeStance Health (LFST) United States $2.326B 0.00
Astrana Health (ASTH) United States $2.077B 26.21
U.S Physical Therapy (USPH) United States $1.558B 40.39
Addus HomeCare (ADUS) United States $1.538B 23.57
Pennant (PNTG) United States $0.643B 37.58
Aveanna Healthcare Holdings (AVAH) United States $0.437B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00